| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Over the past 90 days, insiders at Madrigal Pharmaceuticals, Inc. (MDGL) have been net sellers, shedding 12,247 shares worth roughly $6.6M on balance.
MDGL sits in the Biotechnology industry within the Health Care sector, so this activity is best read against the sector's broader insider trend.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 1.95M | - | - | |
| Dir | 452.7K | - | - | |
| CEO | 197.7K | $108.04M | - | |
| Dir | 187.2K | $99.04M | - | |
| Dir | 22.5K | - | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 11, 2026 | Sibold William John | President and CEO | Sell10b5-1 | 11,583 | $538.65 | $6,239,198.15 | -5.5% | - | - | |
| Aug 17, 2026 | Kelley Shannon T | General Counsel | Sell | 664 | $514.97 | $341,940.08 | -5.5% | - | - | |
| Jul 20, 2026 | Sibold William John | President and CEO | Sale+OE | 2,500 | $547.30 | $1,368,253.45 | -1.2% | -16.5% | - | |
| Jun 1, 2026 | Soergel David | Chief Medical Officer | Sell10b5-1 | 1,042 | $495.74 | $516,561.08 | -9.4% | +12.2% | - | |
| May 22, 2026 | Levy Richard S | Director | Sell10b5-1 | 5,682 | $515.44 | $2,928,716.43 | -20.5% | +0.4% | - | |
| May 18, 2026 | Soergel David | Chief Medical Officer | Sell | 844 | $515.90 | $435,419.60 | -7.1% | +0.5% | - | |
| Mar 6, 2026 | Taub Rebecca | Director | Sell | 491 | $431.94 | $212,082.54 | -0.1% | +13.7% | - | |
| Mar 6, 2026 | Huntsman Carole | Chief Commercial Officer | Sell | 419 | $431.94 | $180,982.86 | -3.2% | +13.7% | - | |
| Mar 6, 2026 | Dier Mardi70 | EVP and CFO | Sell10b5-1 | 1,982 | $430.87 | $853,992.52 | -13.7% | +13.7% | - | |
| Mar 6, 2026 | Sibold William John | President and CEO | Sell | 1,663 | $431.94 | $718,316.22 | -1.0% | +13.7% | - |